U.S. Markets closed

KaloBios Pharmaceuticals, Inc. (KBIO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.64+0.00 (+0.31%)
At close: 3:30PM EDT
People also watch
Full screen
Previous Close1.63
Bid0.00 x
Ask0.00 x
Day's Range1.60 - 1.65
52 Week Range1.50 - 4.75
Avg. Volume7,206
Market Cap24.56M
PE Ratio (TTM)-0.75
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Forbes4 months ago

    Rare Diseases Patients Need More Than Miracles And Trumpcare

    Rare Disease Week was rapidly followed by more proposals to gut the ACA healthcare and the FDA, immigration and travel bans which will decimate research and healthcare (as well as being needless and cruel), and reduce research budgets. How does this help patients?

  • Investopedia10 months ago

    KaloBios Plans Big In The Post-Shkreli Era (KBIO)

    Martin Shkreli’s departure and sale of his stake have allowed KaloBios to focus on a turnaround

  • We're sorry this is all we were able to find about this topic.